BCL2 and acute lymphoblastic leukemia: Correlative BH3 profiling demonstrated frequent BCL-2 and BCL-XL dependency in ALL cells, and the capacity for dependency switching during treatment as a potential mechanism of resistance to BCL-2 inhibition [44].